The National Health Commission said in a notice released on Tuesday that it has recently learned that some medical ...

Alzheimer's disease, which is a neurodegenerative disease that affects ... The fastest growth in older populations is ...

Education -- a proxy for cognitive reserve -- often correlates with better cognition, greater gray matter volume, improved ...

The newly recommended dosing schedule significantly lowered ARIA-E rates compared to the original dosing schedule, adding to the established safety profile of the treatment "We are confident that this ...

Treating the neurodegenerative disease in its earlier stages is key to slowing cognitive decline. A new study offers hope for ...

The 43,000 sq m facility – roughly the size of six football fields – features spaces that replicate familiar settings like a ...

Eli Lilly has chalked up another regulatory approval for its anti-amyloid therapy for Alzheimer's disease, Kisunla, in China – the world's second-largest pharma market. The National Medical ...

Tulane University researchers created a first-of-its-kind subcellular map of an area of the brain commonly affected by ...

The facility gives residents more choice and autonomy in daily living. Read more at straitstimes.com. Read more at ...

Experts say that frequent nightmares can be a marker of earlier dementia and even a driver of it, with cortisol being the ...

This facility is China’s first Alzheimer’s disease care village, built by Singapore-based healthcare and real estate company Perennial Holdings and opened progressively from March 2024. The ...

The newly recommended dosing schedule significantly lowered ARIA-E rates compared to the original dosing schedule, adding to the established safety profile of the treatment INDIANAPOLIS, ...